FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Börse Stuttgart 03:50:07 2024-05-29 pm EDT | ||
| 0.215 EUR | +3.37% |
|
| Current month | -32.90% | ||
| 1 month | -36.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-29 | 0.215 | +3.37% |
| 24-05-28 | 0.208 | +10.64% |
| 24-05-27 | 0.188 | -3.59% |
| 24-05-24 | 0.195 | +0.52% |
| 24-05-23 | 0.194 | +3.74% |
Delayed Quote Börse Stuttgart
Last update May 29, 2024 at 03:50 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MF8NCQ |
| ISIN | DE000MF8NCQ6 |
| Date issued | 2018-11-30 |
| Strike | 400.3 $ |
| Maturity | Unlimited |
| Parity | 444.2 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 14.95 € |
|---|---|
| Lowest since issue | 0.167 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
